Calcium for Bone Fracture

Verdict: Disputed: benefit only in high-risk elderly

The evidence on calcium for fracture prevention is genuinely conflicting and population-dependent: it does little or nothing for healthy community-dwelling adults, and any meaningful benefit is largely confined to calcium combined with vitamin D in frail, institutionalized, or low-intake elderly people. For most people, calcium supplements are not a reliable way to prevent fractures.

C 🟠 C Weak Evidence Disputed

🔬Why this grade7-layer evidence engine

This is graded weak (C) and flagged as disputed because high-quality trials point in opposite directions depending on who is studied. In free-living older adults the signal is essentially null: a large government-funded meta-analysis (PMID 29279934, n=51,145) found combined calcium plus vitamin D did not lower hip fracture (RR 1.09), and the Women's Health Initiative RCT (PMID 16481635, n=36,282) found no benefit in its main analysis (hip-fracture HR 0.88, not significant), with benefit emerging only among adherent women and those 60 and older.

The countervailing evidence comes mostly from higher-risk groups and combined supplementation. The landmark Chapuy trial (PMID 1331788) cut hip fractures ~43% in institutionalized, low-intake, vitamin-D-deficient elderly women, and meta-analyses report reductions for calcium plus vitamin D (PMID 31860103: hip RR 0.84; PMID 26510847: hip RR 0.70). Notably, the largest benefit (PMID 26510847) is industry/advocacy-funded, calcium alone shows the weakest effect, and WHI also recorded more kidney stones (HR 1.17).

Regulators and clinics echo this restraint. The FDA permits only a qualified claim that adequate calcium with vitamin D 'may reduce the risk of osteoporosis,' the UK NHS says a balanced diet should supply calcium and warns high doses can cause stomach upset, the WHO recommends supplementation only for low-intake pregnant women, and Mayo Clinic notes supplements have a 'modest and limited' effect, favoring diet and exercise. Together these put calcium at weak, conditional evidence rather than a general fracture-prevention recommendation.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.48
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Disputed
Confidence
71%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.485
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高階證據未達主導 (1 positive vs 1 negative),由 raw_score 決定
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis
PMID: 29279934 2017 統合分析 n = 51,145
Finding: No significant association between supplementation and fracture risk. Calcium alone RR 1.53 (95% CI 0.97-2.42); vitamin D alone RR 1.21 (95% CI 0.99-1.47); combined calcium+vitamin D RR 1.09 (95% CI 0.85-1.39) for hip fracture. Nonvertebral, vertebral and total fractures similarly null. Authors concluded results do not support routine use in community-dwelling older people.
🟢 High quality Government Effect size: Hip fracture RR (combined Ca+D) 1.09, 95% CI 0.85-1.39 (null)
View on PubMed
Calcium plus Vitamin D Supplementation and the Risk of Fractures (Women's Health Initiative)
PMID: 16481635 2006 隨機對照試驗 n = 36,282
Finding: Calcium plus vitamin D did not significantly reduce hip fracture in the overall intention-to-treat population: HR 0.88 (95% CI 0.72-1.08). Hip bone density was 1.06% higher in the supplemented group. A significant hip-fracture reduction was seen in the per-protocol (adherent) subgroup and in women aged >=60. Risk of renal calculi increased (HR 1.17, 95% CI 1.02-1.34).
🟢 High quality Government Effect size: Hip fracture HR 0.88, 95% CI 0.72-1.08 (NS in ITT analysis)
View on PubMed
Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-analysis
PMID: 31860103 2019 統合分析 n = 49,282
Finding: Vitamin D supplementation alone showed no fracture benefit (RR 1.06, 95% CI 0.98-1.14). Combined vitamin D plus calcium reduced any fracture by 6% (RR 0.94, 95% CI 0.89-0.99) and hip fracture by 16% (RR 0.84, 95% CI 0.72-0.97). Observational data showed each 10 ng/mL rise in 25(OH)D associated with RR 0.93 (95% CI 0.89-0.96).
🟢 High quality Government Effect size: Combined Ca+D: any fracture RR 0.94 (0.89-0.99); hip fracture RR 0.84 (0.72-0.97)
View on PubMed
Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation
PMID: 26510847 2016 統合分析 n = 30,970
Finding: Calcium plus vitamin D associated with a 15% reduced risk of total fractures (summary RR 0.85, 95% CI 0.73-0.98) and a 30% reduced risk of hip fractures (summary RR 0.70, 95% CI 0.56-0.87) across 2231 total and 195 hip fractures. Trials included institutionalised and community populations.
⚠️ Industry-funded Effect size: Total fracture RR 0.85 (0.73-0.98); hip fracture RR 0.70 (0.56-0.87)
View on PubMed
Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women (Chapuy trial)
PMID: 1331788 1992 隨機對照試驗 n = 3,270
Finding: In low-intake institutionalised elderly women, supplementation produced a significant 43% reduction in hip fracture (21 vs 37, P=0.043) and a 32% reduction in other nonvertebral fractures (66 vs 97, P=0.015) over 18 months. This is the landmark trial supporting benefit in the institutionalised/low-intake elderly subgroup.
Effect size: Hip fracture RR ~0.57 (43% reduction, P=0.043)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Adequate calcium and vitamin D throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis. source↗
L4b EU EFSA
Supportive
L4c UK NHS
Neutral
Adults aged 19 to 64 need 700mg of calcium a day. ... Taking high doses of calcium (more than 1,500mg a day) could lead to stomach pain and diarrhoea. ... You should be able to get all the calcium you need by eating a varied and balanced diet. source↗
L4d TW TFDA / 衛福部
Supportive
19 歲以上成人鈣質之每日建議攝取量為 1000 毫克;鈣之上限攝取量(UL)為每日 2500 毫克。 source↗
L4e WHO
Cautious
In populations with low dietary calcium intake, daily calcium supplementation (1.5 g-2.0 g oral elemental calcium) is recommended for pregnant women to reduce the risk of pre-eclampsia. source↗
L5a NIH Office of Dietary Supplements
Supportive
L5b Mayo Clinic
Cautious
Recent evidence suggests that increasing calcium intake through supplements has a modest and limited effect on bone density. Ingesting the recommended daily amounts of calcium primarily through dietary sources and staying physically active appear to be the best approaches to limit your fracture risk. source↗
L5c Cleveland Clinic
Cautious
L5d Harvard Health
Cautious
L5e Specialty Society (condition-mapped)
Supportive
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-bone-fracture-INT-calcium-001 繁體中文版 →